SMAD4 Pathogenic Variants in Seven New Brazilian Individuals With Myhre Syndrome Including a New Family
American Journal of Medical Genetics Part A · 2025
DOI: 10.1002/ajmg.a.63984 ↗Kurz gefasst
Fallbericht in der Zeitschrift American Journal of Medical Genetics Part A, 2025. Verfasst von Samira Spineli-Silva und 9 weiteren Autor:innen. Beteiligte Einrichtung: Medical Genetics and Genomic Medicine-Department of Translational Medicine, School of Medical Sciences, Campinas, Brazil. Hauptthemen laut MEDLINE: Smad4 Protein, Intellectual Disability, Cryptorchidism, Hand Deformities, Congenital. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 14 Literaturangaben. Gefördert von: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Fundação de Amparo à Pesquisa do Estado de São Paulo, Conselho Nacional de Desenvolvimento Científico e Tecnológico.
Abstract (Originalsprache)
Myhre syndrome is a rare disorder caused by pathogenic gain‐of‐function variants in the SMAD4 gene. Most of the patients have had de novo variants. There are several instances of autosomal dominant inheritance, and penetrance appears to be complete. We describe seven Brazilian patients, three of whom are siblings carrying the recurrent c.1486C>T p.(Arg496Cys) variant in SMAD4 inherited from the father. The other three patients are unrelated simplex cases. All affected individuals have clinical features commonly found in Myhre syndrome, including typical dysmorphic facial features, with intra‐ and interfamilial clinical heterogeneity. Five of the patients have developmental delay and/or clinical signs of intellectual disability. However, only one had neuropsychological testing. Only one patient had a diagnosis of autism spectrum disorder. As in previously reported families, this new family has the same c.1486C>T p.(Arg496Cys) variant. This is the first study describing Brazilian patients with Myhre syndrome, highlighting the clinical variability of this rare disease. We reinforce the need to investigate the parents to provide appropriate genetic counseling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical Genetics and Genomic Medicine-Department of Translational Medicine, School of Medical Sciences, Campinas, Brazil.
- Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
- University Hospital, University of Brasilia, Brasilia, Brazil.
- National Institute of Rare Diseases (InRaras Brazil), University of Brasilia, Brasilia, Brazil.
- Faculty of Medicine, University of Brasilia, Brasilia, Brazil.
- Faculty of Medicine, University of Rio de Janeiro, Rio de Janeiro, Brazil.
ORCID-Profile: Juliana Forte Mazzeu, Társis Paiva Vieira
Förderung
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
Zitieren
APA
Spineli-Silva, S., Pontes, L. B., de Leeuw, N., Correia-Costa, G. R., de Wallau, M. B., Versiani, B. R., Mazzeu, J. F., Boy, R., Gil-da-Silva-Lopes, V. L., & Vieira, T. P. (2025). SMAD4 Pathogenic Variants in Seven New Brazilian Individuals With Myhre Syndrome Including a New Family. American Journal of Medical Genetics Part A. https://doi.org/10.1002/ajmg.a.63984
Vancouver
Spineli-Silva S, Pontes LB, de Leeuw N, Correia-Costa GR, de Wallau MB, Versiani BR, et al. SMAD4 Pathogenic Variants in Seven New Brazilian Individuals With Myhre Syndrome Including a New Family. American Journal of Medical Genetics Part A. 2025. doi:10.1002/ajmg.a.63984
BibTeX
@article{SpineliSilva2025,
author = {Spineli-Silva, Samira and Pontes, Larissa Bretanha and de Leeuw, Nicole and Correia-Costa, Gabriela Roldão and de Wallau, Melissa Bittencourt and Versiani, Beatriz Ribeiro and Mazzeu, Juliana Forte and Boy, Raquel and Gil-da-Silva-Lopes, Vera Lúcia and Vieira, Társis Paiva},
title = {SMAD4 Pathogenic Variants in Seven New Brazilian Individuals With Myhre Syndrome Including a New Family},
journal = {American Journal of Medical Genetics Part A},
year = {2025},
doi = {10.1002/ajmg.a.63984}
}
EUVIMED